COVID-19 drug practices risk antimicrobial resistance evolution.

Afshinnekoo E, Bhattacharya C, Burguete-García A, Castro-Nallar E, Deng Y, Desnues C, Dias-Neto E, Elhaik E, Iraola G, Jang S, Łabaj PP, Mason CE, Nagarajan N, Poulsen M, Prithiviraj B, Siam R, Shi T, Suzuki H, Werner J, Zambrano MM, Bhattacharyya M, MetaSUB Consortium

The Lancet Microbe - (-) - [2021-02-24; online 2021-02-24]

Type: Other

PubMed 33655229

DOI 10.1016/S2666-5247(21)00039-2

Crossref 10.1016/S2666-5247(21)00039-2

pii: S2666-5247(21)00039-2
pmc: PMC7906697


Publications 7.1.2